Conmed Statistics
Want to see CNMD full AI Analyst Report?
Conmed (CNMD) Stock Statistics & Valuation Metrics
Total Valuation
Conmed has a market cap or net worth of $1.51B. The enterprise value is $2.16B.
- Market Cap
- $1.51B
- Enterprise Value
- $2.16B
Share Statistics
Conmed has 29,803,324 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,803,324
- Owned by Insiders
- 0.19%
- Owned by Institutions
- 81.04%
Financial Efficiency
Conmed’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.64%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 4.64%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 352.43K
- Profits Per Employee
- 12.07K
- Employee Count
- 3,900
- Asset Turnover
- 0.59
- Inventory Turnover
- 1.83
Valuation Ratios
The current PE Ratio of Conmed is 20.84. Conmed’s PEG ratio is 1.19.
- PE Ratio
- 20.84
- PS Ratio
- 1.10
- PB Ratio
- 1.42
- Price to FCF
- 11.33
- Price to Operating Cash Flow
- 10.31
- PEG Ratio
- 1.19
Income Statement
In the last 12 months, Conmed had revenue of 1.37B and earned 47.05M in profits. Earnings per share was 1.52.
- Revenue
- 1.37B
- Gross Profit
- 725.38M
- Operating Income
- 141.13M
- Pretax Income
- 71.12M
- Net Income
- 47.05M
- EBITDA
- 176.49M
- Earnings Per Share (EPS)
- 1.52
Cash Flow
In the last 12 months, operating cash flow was 146.31M and capital expenditures -13.62M, giving a free cash flow of 132.69M billion.
- Operating Cash Flow
- 146.31M
- Free Cash Flow
- 132.69M
- Free Cash Flow per Share
- 4.43
Dividends & Yields
Conmed pays an annual dividend of $0.20, resulting in a dividend yield of ―
- Dividend Per Share
- $0.20
- Dividend Yield
- ―
- Payout Ratio
- 13.27%
- Free Cash Flow Yield
- 8.84%
- Earnings Yield
- 4.87%
Stock Price Statistics
- Beta
- 0.58
- 52-Week Price Change
- 15.89%
- 50-Day Moving Average
- 47.09
- 200-Day Moving Average
- 41.75
- Relative Strength Index (RSI)
- 56.52
- Average Volume (3m)
- 364.14K
Important Dates
Conmed upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- Sep 15, 2025
Financial Position
Conmed as a current ratio of 2.14, with Debt / Equity ratio of 80.82%
- Current Ratio
- 2.14
- Quick Ratio
- 1.01
- Debt to Market Cap
- 0.66
- Net Debt to EBITDA
- 4.50
- Interest Coverage Ratio
- 4.54
Taxes
In the past 12 months, Conmed has paid 24.06M in taxes.
- Income Tax
- 24.06M
- Effective Tax Rate
- 0.34
Enterprise Valuation
Conmed EV to EBITDA ratio is 10.73, with an EV/FCF ratio of 17.10.
- EV to Sales
- 1.66
- EV to EBITDA
- 10.73
- EV to Free Cash Flow
- 17.10
- EV to Operating Cash Flow
- 15.51
Balance Sheet
Conmed has $47.97M in cash and marketable securities with $815.87M in debt, giving a net cash position of -$767.89M billion.
- Cash & Marketable Securities
- $47.97M
- Total Debt
- $815.87M
- Net Cash
- -$767.89M
- Net Cash Per Share
- -$25.77
- Tangible Book Value Per Share
- -$9.81
Margins
Gross margin is 57.20%, with operating margin of 12.11%, and net profit margin of 5.36%.
- Gross Margin
- 57.20%
- Operating Margin
- 12.11%
- Pretax Margin
- 7.66%
- Net Profit Margin
- 5.36%
- EBITDA Margin
- 15.43%
- EBIT Margin
- 10.11%
Analyst Forecast
The average price target for Conmed is $47.25, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $47.25
- Price Target Upside
- 6.40% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 5
- Revenue Growth Forecast
- 1.93%
- EPS Growth Forecast
- 16.93%
Scores
- Smart Score
- 5
- AI Score
- 62
